Deuterated Iridium OLED Emitters for Longer Phosphorescent Lifetime

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing organic light-emitting diodes (OLEDs) face challenges in achieving improved lifetime and efficiency, particularly in commercial applications, especially when using phosphorescent emissive materials.

Innovation Solution

The use of heteroleptic iridium compounds with deuterated alkyl groups in the 5th position of the pyridine ring, and homoleptic tris-iridium complexes with deuterated alkyl groups, which enhance the lifetime and suitability for commercial applications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Use of energy by moving object

If phosphorescent emissive materials are used in OLEDs, then efficiency is improved, but lifetime is reduced

Engineering Contradiction:
ImproveefficiencyVSAvoidlifetime
Core Design Contradiction:
Use of energy by moving objectVSDuration of action of stationary object

Solution Approach 1:

The patent applies parameter changes by deuterating the alkyl groups at the 5th position of the pyridine ring in iridium compounds. This isotopic substitution changes the physical and chemical parameters of the material, specifically improving molecular stability and reducing degradation rates, thereby extending device lifetime while preserving phosphorescent emission efficiency

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite material strategies by combining heteroleptic and homoleptic tris-iridium complexes with deuterated ligands in the emissive layer. This creates a composite phosphorescent system that leverages the complementary properties of different iridium complex structures to achieve both high efficiency and extended lifetime

Inventive Principle:
Principle #40Composite materials

2Duration of action of stationary object

If heteroleptic iridium compounds with deuterated alkyl groups are used, then lifetime is improved, but manufacturing complexity increases

Engineering Contradiction:
ImprovelifetimeVSAvoidmanufacturing complexity
Core Design Contradiction:
Duration of action of stationary objectVSEase of manufacture

Solution Approach 1:

The patent applies local quality by selectively deuterating only the alkyl groups at the 5th position of the pyridine ring rather than the entire molecule. This localized modification targets the specific region that influences stability and lifetime, while minimizing the overall complexity of synthesis and manufacturing

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These compounds exhibit unexpectedly improved lifetime, making them more suitable for commercial applications in OLEDs, such as consumer products and lighting panels.

Implementation Method 1

OLEDs make use of thin organic films that emit light when voltage is applied across the device... One application for phosphorescent emissive molecules is a full color display

Methodology Applied
Scientific EffectPhosphorescence: Phosphorescence

Data Source

PatentUS12527214B2Organic electroluminescent materials and devices
Publication Date: 2026.01.13 UNIVERSAL DISPLAY CORP
  • US12527214B2 patent drawing
  • US12527214B2 patent drawing
  • US12527214B2 patent drawing

AI summary

A metal iridium complexes, devices containing the same, and formulations including the same described. The complexes can have the formula Ir(L1)n(L2)3-n, whereinthe first ligand L1 has Formula I,the second ligand L2 has Formula II,L1 is different from L2; R1 is a partially or fully deuterated group consisting of alkyl and cycloalkyl; R2 represents mono, di, tri substitutions or no substitution; R3, R4, and R5 each represent mono, di, tri, tetra substitutions or no substitution; R2 and R3 are each independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof; R4 and R5 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and n is 1 or 2. Homoleptic, tris-iridium complex including deuterated alkyl groups are also described.